Profile for Colombia Patent: 2021007172
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for Colombia Patent: 2021007172
| US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
|---|---|---|---|---|
| ⤷ Start Trial | Nov 1, 2039 | Biocryst | ORLADEYO | berotralstat dihydrochloride |
| ⤷ Start Trial | Nov 1, 2039 | Biocryst | ORLADEYO | berotralstat dihydrochloride |
| ⤷ Start Trial | Nov 1, 2039 | Biocryst | ORLADEYO | berotralstat dihydrochloride |
| ⤷ Start Trial | Nov 1, 2039 | Biocryst | ORLADEYO | berotralstat dihydrochloride |
| ⤷ Start Trial | May 1, 2040 | Biocryst | ORLADEYO | berotralstat dihydrochloride |
| ⤷ Start Trial | May 1, 2040 | Biocryst | ORLADEYO | berotralstat dihydrochloride |
| ⤷ Start Trial | May 1, 2040 | Biocryst | ORLADEYO | berotralstat dihydrochloride |
| >US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |
